Christopher Gibson - 18 Apr 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
18 Apr 2022
Net transactions value
-$152,697
Form type
4
Filing time
20 Apr 2022, 21:03:17 UTC
Previous filing
18 Apr 2022
Next filing
25 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $109,145 +44,010 +12% $2.48 412,127 18 Apr 2022 Direct F1
transaction RXRX Class A Common Stock Sale $121,175 -17,336 -4.2% $6.99 394,791 18 Apr 2022 Direct F1, F2
transaction RXRX Class A Common Stock Conversion of derivative security $0 +18,500 +4.7% $0.000000 413,291 18 Apr 2022 Direct F1, F3, F4
transaction RXRX Class A Common Stock Sale $123,896 -18,500 -4.5% $6.70 394,791 18 Apr 2022 Direct F1, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +500 $0.000000 500 18 Apr 2022 by LAHWRAN-3 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale $3,358 -500 -100% $6.72 0 18 Apr 2022 by LAHWRAN-3 LLC F1, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 18 Apr 2022 by LAHWRAN-4 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale $6,706 -1,000 -100% $6.71 0 18 Apr 2022 by LAHWRAN-4 LLC F1, F7
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 18 Apr 2022 by Gibson Family Trust F1, F3, F4
transaction RXRX Class A Common Stock Sale $6,706 -1,000 -100% $6.71 0 18 Apr 2022 by Gibson Family Trust F1, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -18,500 -0.27% $0.000000 6,929,834 18 Apr 2022 Class A Common Stock 6,929,834 $0.000000 Direct F1, F3, F4
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -44,010 -3.5% $0.000000 1,207,294 18 Apr 2022 Class A Common Stock 1,207,294 $2.48 Direct F1, F10
transaction RXRX Class B Common Stock Conversion of derivative security $0 -500 -0.09% $0.000000 547,000 18 Apr 2022 Class A Common Stock 547,000 $0.000000 by LAHWRAN-3 LLC F1, F3, F4, F11
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.18% $0.000000 544,000 18 Apr 2022 Class A Common Stock 544,000 $0.000000 by LAHWRAN-4 LLC F1, F3, F4, F12
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.7% $0.000000 140,875 18 Apr 2022 Class A Common Stock 140,875 $0.000000 by Gibson Family Trust F1, F3, F4, F13
holding RXRX Stock Option (Right to Buy) 416,350 18 Apr 2022 Class A Common Stock 416,350 $11.40 Direct F9
holding RXRX Stock Option (Right to Buy) 5,436 18 Apr 2022 Class A Common Stock 5,436 $11.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $6.98 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Represents the conversion of Class B Common Stock into Class A Common Stock.
F4 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F5 This transaction was executed in multiple trades at prices ranging from $6.46 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $6.46 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $6.47 to $7.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $6.46 to $7.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F11 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F12 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F13 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.